Bicyclic heteroaryl compounds

What is AI technical title?
AI technical title is built by Patsnap AI team. It summarizes the technical point description of the patent document.
Novel bicyclic heteroaryl compounds are developed to inhibit PARG enzyme activity, addressing the need for effective cancer treatment by sensitizing cells to DNA damage and impairing cancer cell survival, providing a range of administration options.

HK40135206APending Publication Date: 2026-07-17CONTEX BIOTECH USA INC

Patent Information

Authority / Receiving Office: HK · HK
Patent Type: Applications
Current Assignee / Owner: CONTEX BIOTECH USA INC
Filing Date: 2026-06-09
Publication Date: 2026-07-17

Patent Text Reader

Abstract

Provided herein are novel compounds (e.g., Formula I), pharmaceutical compositions, and methods of use for the treatment of various diseases or disorders, such as cancer. Formula I

Need to check novelty before this filing date? Find Prior Art